Atlas Molecular Pharma
Developing new pharmacological chaperones for the treatment of rare metabolic diseases.
Atlas Molecular Pharma has raised €3.0M across 1 funding round from 3 investors, most recently a round in Feb 2022. Based in Derio, Spain; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€3.0M
€3,000,000
Funding rounds
1
Investors
3
distinct backers
Active since
2022-02
latest 2022-02
Funding by year
EUR raised per yearAtlas Molecular Pharma — funding by year — interactive chart.
Data table
| Atlas Molecular Pharma — funding by year | |
|---|---|
| 2022 | €3.0M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-02-01 | Other | €3.0M | CDTI,Ezten Venture Capital Fund,Inveready | View deal → |
Investors
3Related news
- Atlas Molecular Pharma cierra una ronda de €3M liderada por Inveready, CDTI y EZTEN. Acuden también socios actualeswebcapitalriesgo.com · 2022-02
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Jobandtalent€1.4BSpain · HRtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Perk (formerly TravelPerk)€1.1BSpain · Travel
Global coverage: FundingData